Try our Advanced Search for more refined results
March 15, 2017
DOW PHARMACEUTICAL SCIENCES, INC. et al v. ACTAVIS LABORATORIES UT, INC. et al
Case Number:
2:17-cv-01706
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
March 15, 2017
Dow Hits Teva, Actavis With Suit Over Generic Acne Med
Dow Pharmaceutical Sciences Inc. and Valeant Pharmaceuticals slapped Actavis Laboratories UT Inc. with a patent infringement suit in New Jersey federal court Wednesday over Actavis' abbreviated new drug application to market a generic form of Valeant anti-acne gel Onexton.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login